Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2013 2
2014 3
2015 2
2016 1
2017 5
2018 4
2019 3
2020 6
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Mineral bone disease in autosomal dominant polycystic kidney disease.
Gitomer B, Pereira R, Salusky IB, Stoneback JW, Isakova T, Cai X, Dalrymple LS, Ofsthun N, You Z, Malluche HH, Maddux F, George D, Torres V, Chapman A, Steinman TI, Wolf M, Chonchol M. Gitomer B, et al. Kidney Int. 2021 Apr;99(4):977-985. doi: 10.1016/j.kint.2020.07.041. Epub 2020 Sep 11. Kidney Int. 2021. PMID: 32926884
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.
Hanudel MR, Salusky IB, Pereira RC, Wang W, You Z, Nowak KL, Brosnahan GM, Torres VE, Chapman AB, Perrone RD, Steinman TI, Bae KT, Gitomer BY, Chonchol MB. Hanudel MR, et al. Among authors: gitomer by. Kidney Int Rep. 2019 Aug 24;4(12):1742-1748. doi: 10.1016/j.ekir.2019.08.010. eCollection 2019 Dec. Kidney Int Rep. 2019. PMID: 31844811 Free PMC article. No abstract available.
Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.
Hopp K, Cornec-Le Gall E, Senum SR, Te Paske IBAW, Raj S, Lavu S, Baheti S, Edwards ME, Madsen CD, Heyer CM, Ong ACM, Bae KT, Fatica R, Steinman TI, Chapman AB, Gitomer B, Perrone RD, Rahbari-Oskoui FF, Torres VE; HALT Progression of Polycystic Kidney Disease Group, the ADPKD Modifier Study, Harris PC. Hopp K, et al. Among authors: gitomer b. Kidney Int. 2020 Feb;97(2):370-382. doi: 10.1016/j.kint.2019.08.038. Epub 2019 Oct 9. Kidney Int. 2020. PMID: 31874800 Free PMC article.
Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.
Nowak KL, Gitomer B, Farmer-Bailey H, Wang W, Malaczewski M, Klawitter J, You Z, George D, Patel N, Jovanovich A, Chonchol M. Nowak KL, et al. Among authors: gitomer b. Am J Kidney Dis. 2019 Aug;74(2):213-223. doi: 10.1053/j.ajkd.2018.12.037. Epub 2019 Feb 23. Am J Kidney Dis. 2019. PMID: 30803706 Free PMC article. Clinical Trial.
Predictors of autosomal dominant polycystic kidney disease progression.
Schrier RW, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Friend K, Gitomer B, Rossetti S. Schrier RW, et al. Among authors: gitomer b. J Am Soc Nephrol. 2014 Nov;25(11):2399-418. doi: 10.1681/ASN.2013111184. Epub 2014 Jun 12. J Am Soc Nephrol. 2014. PMID: 24925719 Free PMC article. Review.
Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participants.
Nowak KL, Farmer-Bailey H, Cadnapaphornchai MA, You Z, George D, Wang W, Jovanovich A, Soranno DE, Gitomer B, Chonchol M. Nowak KL, et al. Among authors: gitomer b. Contemp Clin Trials Commun. 2020 Aug 12;19:100635. doi: 10.1016/j.conctc.2020.100635. eCollection 2020 Sep. Contemp Clin Trials Commun. 2020. PMID: 33294724 Free PMC article.
CD8+ T cells modulate autosomal dominant polycystic kidney disease progression.
Kleczko EK, Marsh KH, Tyler LC, Furgeson SB, Bullock BL, Altmann CJ, Miyazaki M, Gitomer BY, Harris PC, Weiser-Evans MCM, Chonchol MB, Clambey ET, Nemenoff RA, Hopp K. Kleczko EK, et al. Among authors: gitomer by. Kidney Int. 2018 Dec;94(6):1127-1140. doi: 10.1016/j.kint.2018.06.025. Epub 2018 Sep 21. Kidney Int. 2018. PMID: 30249452 Free PMC article.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page